category
PNAS
date
Feb 11, 2026
slug
status
Published
summary
通过基因工程改造巨核细胞使其在体内生成具有溶瘤特性的血小板,克服传统溶瘤病毒系统给药时的抗体介导限制,提升癌症免疫治疗效果。
tags
合成生物学
基因编辑
核酸蛋白工具酶
type
Post

📄 原文题目

Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy

🔗 原文链接

💡 AI 核心解读

通过基因工程改造巨核细胞使其在体内生成具有溶瘤特性的血小板,克服传统溶瘤病毒系统给药时的抗体介导限制,提升癌症免疫治疗效果。

📝 英文原版摘要

Proceedings of the National Academy of Sciences, Volume 123, Issue 7, February 2026. <br />SignificanceOncolytic viruses (OVs) are emerging as promising cancer therapeutics that selectively kill tumor cells and induce antitumor immunity. However, therapeutic effectiveness of OVs via systemic administration is limited by antibody-mediated ...
胰腺β细胞增殖的遗传记录无前导序列的RiPPs扩展真菌次级代谢产物的多样性
Loading...